Skip to main content
. Author manuscript; available in PMC: 2008 Jul 10.
Published in final edited form as: Int J Cardiol. 2006 Oct 18;119(2):192–195. doi: 10.1016/j.ijcard.2006.07.132

Table 2.

Prevalence of CHD risk factors and therapies of the study cohort at baseline

CHD Risk Factor Prevalence
Male 66%
Caucasian 70%
Hypertension 42%
Smoker (active) 15%
Diabetes mellitus 16%
Metabolic Syndrome 33%
Coronary Disease 36%
Cerebrovascular disease 5%
Peripheral Arterial Disease 5%
Treatment (baseline)
Statins 36%
Fibrates 17%
Niacin 4%
Bile Acid Resins 3%
Fish Oils 2%